Lisa M. McShane

Active 1992–2025

109
Papers
46,246
Citations
81
h-index
104
i10-index

Citations

Citations per year for Lisa M. McShane1972: 1 citations1977: 1 citations1987: 2 citations1992: 1 citations1993: 7 citations1994: 11 citations1995: 6 citations1996: 22 citations1997: 18 citations1998: 33 citations1999: 26 citations2000: 18 citations2001: 36 citations2002: 53 citations2003: 76 citations2004: 112 citations2005: 161 citations2006: 203 citations2007: 204 citations2008: 258 citations2009: 230 citations2010: 271 citations2011: 368 citations2012: 389 citations2013: 384 citations2014: 442 citations2015: 417 citations2016: 387 citations2017: 405 citations2018: 351 citations2019: 1,231 citations2020: 1,384 citations2021: 1,335 citations2022: 1,050 citations2023: 880 citations2024: 1,389 citations2025: 665 citations2026: 37 citations1973–1976: no citations, so these years are not shown1978–1986: no citations, so these years are not shown1988–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,227 citing papers, 23.6% of this breakdownChina: 1,479 citing papers, 8.2% of this breakdownUnited Kingdom: 1,410 citing papers, 7.9% of this breakdownItaly: 1,005 citing papers, 5.6% of this breakdownGermany: 971 citing papers, 5.4% of this breakdownCanada: 746 citing papers, 4.2% of this breakdownFrance: 680 citing papers, 3.8% of this breakdownNetherlands: 594 citing papers, 3.3% of this breakdownSpain: 587 citing papers, 3.3% of this breakdownJapan: 494 citing papers, 2.8% of this breakdownAustralia: 474 citing papers, 2.6% of this breakdownSouth Korea: 434 citing papers, 2.4% of this breakdown
0%23.6%Other 26.9%

Fields

  • Medicine46.9%
  • Biochemistry, Genetics and Molecular Biology39.3%
  • Computer Science3.8%
  • Neuroscience3.7%
  • Immunology and Microbiology1.4%
  • Engineering0.9%
  • Other4%

Topics

  • Breast Cancer Treatment Studies7.1%
  • HER2/EGFR in Cancer Research5%
  • Cancer Genomics and Diagnostics4.2%
  • Radiomics and Machine Learning in Medical Imaging3%
  • Cancer Immunotherapy and Biomarkers2.7%
  • Gene expression and cancer classification2.4%
  • Other75.6%

Coauthors

All papers

Open in search
  1. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 1,497

  2. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update

    Authors: , , , , , , , , - Journal of Clinical Oncology 2023 cited by 581

  3. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

    Authors: , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2018 cited by 2,454

  4. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James L. Wittliff, Antonio C. Wolff - Archives of Pathology & Laboratory Medicine 2010 cited by 4,267

  5. Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2020 cited by 733

  6. Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2011 cited by 1,996

  7. Criteria for the translation of radiomics into clinically useful tests

    Authors: , , , , , , , - Nature Reviews Clinical Oncology 2022 cited by 217

  8. TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository

    Authors: , , , , , , , , , - Journal of Translational Medicine 2021 cited by 521

  9. Imaging biomarker roadmap for cancer studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Erich P. Huang, Brian Hutton, Edward F. Jackson, Gordon C. Jayson, Andrew Jones, Dow‐Mu Koh, Denis Lacombe, Philippe Lambin, Nathalie Lassau, Martin O. Leach, Ting-Yim Lee, Edward Leen, Jason S. Lewis, Yan Liu, Mark F. Lythgoe, Prakash Manoharan, Ross J. Maxwell, Kenneth A. Miles, Bruno Morgan, Steve Morris, Tony Ng, Anwar R. Padhani, Geoff J.M. Parker, Mike Partridge, Arvind P. Pathak, Andrew C. Peet, Shonit Punwani, Andrew R. Reynolds, Simon P. Robinson, Lalitha Shankar, Ricky A. Sharma, Dmitry Soloviev, Sigrid Stroobants, Daniel C. Sullivan, Stuart A. Taylor, Paul S. Tofts, Gillian M. Tozer, Marcel van Herk, Simon Walker‐Samuel, James Wason, Kaye J. Williams, Paul Workman, Thomas E. Yankeelov, Kevin M. Brindle, Lisa M. McShane, Alan Jackson, John C. Waterton - Nature Reviews Clinical Oncology 2016 cited by 1,078

  10. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Albrecht Stenzinger, Mark Stewart, Jeff Allen - Journal for ImmunoTherapy of Cancer 2020 cited by 506

  11. Dabrafenib and Trametinib in Patients With Tumors With BRAFV600E Mutations: Results of the NCI-MATCH Trial Subprotocol H

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 296

  12. REporting recommendations for tumour MARKer prognostic studies (REMARK)

    Authors: , , , , , - British Journal of Cancer 2005 cited by 1,387

  13. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

    Authors: , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2013 cited by 4,061

  14. Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

    Authors: , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2020 cited by 369

  15. The NCI-MATCH trial: lessons for precision oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 cited by 183

  16. Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarabjot Pabla, Aparna Pallavajjalla, Gary A. Pestano, Roberto Salgado, Raed Samara, Ethan S. Sokol, Phillip Stafford, Jan Budczies, Albrecht Stenzinger, W Tom, Kenneth C. Valkenburg, X.Z. Wang, Victor Weigman, Mingchao Xie, Qiqi Xie, Ahmet Zehir, Chen Zhao, Yiqiang Zhao, Mark Stewart, Jeff Allen - Annals of Oncology 2021 cited by 182

  17. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration

    Authors: , , , , - JNCI Journal of the National Cancer Institute 2018 cited by 495

  18. Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 295

  19. Statistical analysis of high-dimensional biomedical data: a gentle introduction to analytical goals, common approaches and challenges

    Authors: , , , , , , , , , , , - BMC Medicine 2023 cited by 88

  20. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2006 cited by 4,475

  21. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James L. Wittliff, Antonio C. Wolff - Archives of Pathology & Laboratory Medicine 2010 cited by 1,048

  22. Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 129

  23. An International Ki67 Reproducibility Study

    Authors: , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2013 cited by 598

  24. Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment

    Authors: , , , , , , , , , , , , , , , , , - Statistical Methods in Medical Research 2014 cited by 384